Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Sell
5,362
-5,362
-50% -$191K ﹤0.01% 1060
2026
Q1
$322K Buy
+10,724
New +$340K ﹤0.01% 837
2025
Q1
Sell
-30
Closed -$638 2259
2024
Q4
$638 Buy
+30
New +$657 ﹤0.01% 1966

Other funds holding IX

Clearstead Advisors's IX Position: Q2 2026 in Review

Clearstead Advisors reduced its ORIX (IX) stake by 50% in Q2 2026, selling an estimated $191K and leaving 5,362 shares worth $204K. The position accounts for ﹤0.01% of the portfolio, ranked #1060.

Clearstead Advisors first reported a position in IX in Q4 2024 and has held it in 3 quarters since. The position peaked at $322K in Q1 2026. 320 funds tracked by Wall St. Rank hold IX as of Q2 2026.

  • Clearstead Advisors held 5,362 shares of ORIX worth $204K as of Q2 2026.
  • Clearstead Advisors sold 5,362 ORIX shares in Q2 2026, an estimated $191K.
  • ORIX made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1060 holding.
  • Clearstead Advisors first reported a position in ORIX in Q4 2024 and has held it in 3 quarters since.
  • Clearstead Advisors's ORIX position peaked at $322K in Q1 2026.
  • 320 funds tracked by Wall St. Rank held ORIX as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.